- Primary Angiosarcoma of the Breast: A Case Report
-
Kim RM, Lee H, Park H
- KMID: 2434907
- J Breast Dis.
- 2018 Dec;6(2):73-78.
- doi: 10.14449/jbd.2018.6.2.73
Primary angiosarcoma of the breast is extremely rare and is observed in 0.0005% to 0.05% of primary breast tumor cases. The diagnosis of this tumor is difficult due to its... -
- CITED
-
- Close
- SHARE
-
- Close
- Synchronous Bilateral Breast Carcinoma in a Patient with Cowden Syndrome with PTEN Mutation: A Case Report
-
Kwon SY, Yeo SH, Ha JS, Kang SH
- KMID: 2434908
- J Breast Dis.
- 2018 Dec;6(2):79-83.
- doi: 10.14449/jbd.2018.6.2.79
Cowden syndrome (CS), also known as multiple hamartomas syndrome, is a rare hereditary autosomal dominant disorder caused by a germline mutation in the phosphatase and tensin homolog (PTEN) gene mapped... -
- CITED
-
- Close
- SHARE
-
- Close
- Apoptosis and Cell Cycle Arrest in Two Human Breast Cancer Cell Lines by Dieckol Isolated from Ecklonia cava
-
You SH, Kim JS, Kim YS
- KMID: 2434903
- J Breast Dis.
- 2018 Dec;6(2):39-45.
- doi: 10.14449/jbd.2018.6.2.45
PURPOSE: Dieckol, a phlorotannin compound isolated from Ecklonia cava, has been reported to have antioxidant, antiviral, anti-inflammatory, and anticancer properties. The purpose of this study was to investigate its anticancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Combined Aromatase Inhibitor and Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Metastatic Breast Cancer
-
Kim SH, Choi J, Park CS, Kim HA, Noh WC, Seong MK
- KMID: 2434904
- J Breast Dis.
- 2018 Dec;6(2):46-51.
- doi: 10.14449/jbd.2018.6.2.46
PURPOSE: Endocrine therapy is the preferred treatment for hormone receptor (HR)-positive metastatic breast cancer (MBC). We investigated the efficacy of combined aromatase inhibitor (AI) and luteinizing hormone-releasing hormone (LHRH) agonist... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of an Excel Program for the Updated Eighth American Joint Committee on Cancer Breast Cancer Staging System
-
Jo J, Kim ET, Min JW, Chang MC
- KMID: 2434902
- J Breast Dis.
- 2018 Dec;6(2):35-38.
- doi: 10.14449/jbd.2018.6.2.35
PURPOSE: The eighth American Joint Committee on Cancer staging system for breast cancer was recently published to more accurately predict the prognosis by adding biomarkers such as estrogen receptors, progesterone... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Implications According to Diagnostic Methods of Human Epidermal Growth Factor Receptor 2 Positivity in Breast Cancer: A Retrospective Study
-
Kim BK, Jeong J, Han W, Yoon TI, Seong MK, Jung JH, Jung SH, Lee J, Sun WY, Korean Breast Cancer Society
- KMID: 2434906
- J Breast Dis.
- 2018 Dec;6(2):60-72.
- doi: 10.14449/jbd.2018.6.2.60
PURPOSE: According to American Society of Clinical Oncology/College of American Pathologists guidelines, breast cancer is human epidermal growth factor receptor 2 (HER2) positive if there is HER2 protein overexpression at... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicting Successful Conservative Surgery after Neoadjuvant Chemotherapy in Hormone Receptor-Positive, HER2-Negative Breast Cancer
-
Ko CS, Kim KM, Lee JW, Lee HS, Lee SB, Sohn G, Kim J, Kim HJ, Chung IY, Ko BS, Son BH, Ahn SD, Kim SB, Kim HH, Ahn SH
- KMID: 2434905
- J Breast Dis.
- 2018 Dec;6(2):52-59.
- doi: 10.14449/jbd.2018.6.2.52
PURPOSE: This study aimed to determine whether clinicopathological factors are potentially associated with successful breast-conserving surgery (BCS) after neoadjuvant chemotherapy (NAC) and develop a nomogram for predicting successful BCS candidates,... -
- CITED
-
- Close
- SHARE
-
- Close
